Illustrative image – not actual.Biocon India has plans to invest Rs.75 crore in its anti-cancer venture at Bangalore. The project would be based on monoclonal anti-bodies (MAB).

Loading...
Featured today
Loading the latest stories…
Project News • Drug Formulations
Biocon India has plans to invest Rs.75 crore in its anti-cancer venture at Bangalore. The project would be based on monoclonal anti-bodies (MAB).
Illustrative image – not actual.Biocon India has plans to invest Rs.75 crore in its anti-cancer venture at Bangalore. The project would be based on monoclonal anti-bodies (MAB).